REGENXBIO Inc. (RGNX) NASDAQ
6.53
-0.61(-8.54%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
6.53
-0.61(-8.54%)
Currency In USD
| Market Cap | 742.65M |
| Enterprise Value | 968.7M |
| P/E Ratio | -1.18 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 3.84 |
| Price/Book Ratio | 16.23 |
| Enterprise/Revenue | 4.48 |
| Enterprise/EBITDA | -1.67 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -3.3 |
| Operating Margin | -2.92 |
| Return On Assets | -0.85 |
| Return On Equity | -2.32 |
| Revenue | 170.44M |
| Revenue/Share | 1.68 |
| Gross Profit | 150.14M |
| EBITDA | -145.58M |
| Net Income | -193.88M |
| Diluted EPS | -3.76 |
| Total Cash | 150.49M |
| Total Cash/Share | 2.87 |
| Total Debt | 71.07M |
| Total Debt/Equity | 3.37 |
| Current Ratio | 2.62 |
| Book Value Per Share | 0.4 |
| 52-Week Change | -36.91 |
| 52-Week High | 16.19 |
| 52-Week Low | 5.46 |
| Moving Average 50 Days | 8.37 |
| Moving Average 200 Days | 10.47 |
| Average Volume | 1.19M |
| Shares Outstanding | 51.7M |
| % Held by Institutions | 82.59 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |